P20—Agalsidase Beta Treatment is Associated With Improvement in Quality of Life in Patients With Fabry Disease: Findings From the Fabry Registry
Titel:
P20—Agalsidase Beta Treatment is Associated With Improvement in Quality of Life in Patients With Fabry Disease: Findings From the Fabry Registry
Auteur:
Feldt-Rasmussen, U. Watt, T. Burlina, A.P. Cazzorla, C. Schönfeld, D. Banikazemi, M. Hopkin, R.J. Martins, A.M. Sims, K. Beitner-Johnson, D. O'Brien, F.